All posts tagged "Biotech and Pharmaceuticals"
-
Analysis
Pfizer expands charge cuts, tops quarterly benefit estimates at the same time as gross sales fall
29 April 2025The Pfizer emblem is noticeable out of doors the pharmaceutical corporate’s production plant, in Newbridge, Eire...
-
Analysis
Novartis posts better-than-expected first-quarter gross sales, raises full-year steerage
29 April 2025Common view of the Swiss pharmaceutical and drug corporate Novartis AG headquarters on April 11, 2025...
-
Analysis
Why we’re decreasing our Bristol Myers value goal regardless of an profits beat, steerage carry
24 April 2025Bristol Myers Squibb ‘s profits beat and rosy outlook Thursday didn’t unravel lingering problems for the...
-
Analysis
Merck lowers benefit outlook, in part because of $200 million anticipated tariff clash
24 April 2025Nurphoto | Nurphoto | Getty Pictures Merck on Thursday decreased its full-year benefit steerage, bringing up...
-
Analysis
Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for price lists
24 April 2025FILE PHOTO: The Bristol Myers Squibb analysis and construction middle at Cambridge Crossing in Cambridge, Massachusetts,...
-
Analysis
Walgreens tops estimates as drugstore chain cuts prices, prepares to advance non-public
8 April 2025An indication for US drugstore chain Walgreens is displayed outdoor its collect in Unused York Town...
-
Analysis
Moderna beats on income however loses greater than anticipated because it scales ill production
14 February 2025Moderna on Friday posted fourth-quarter revenue that beat estimates, however misplaced greater than anticipated for the...
-
Analysis
Biogen beats estimates on charge cuts and unused medicine like Leqembi, however benefit outlook falls scale down
12 February 2025A check tube is discoverable in entrance of displayed Biogen brand on this representation taken on,...
-
Analysis
CVS stocks pop 10% on weighty income beat, at the same time as top clinical prices drag indisposed insurance coverage unit
12 February 2025CVS Condition on Wednesday reported fourth-quarter income and benefit that crowned estimates, at the same time...
-
Analysis
Bristol Myers Squibb plans $2 billion in charge cuts by means of 2027, problems vulnerable steering
6 February 2025The Bristol Myers Squibb analysis and building heart at Cambridge Crossing in Cambridge, Massachusetts, on Dec....
Trending
